Actively Recruiting
Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma
Led by Istituto Ortopedico Rizzoli · Updated on 2025-03-05
400
Participants Needed
1
Research Sites
100 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
assess whether there is a correlation between some factors (age, sex, tumor volume, tumor site, chemotherapy-induced necrosis, radiation and biomarkers) and overall survival (OS) and relapse-free survival (RFS) in patients with Ewing sarcoma. Identification of reliable prognostic factors could help to identify high-risk patients, which may require a different treatment and follow up.
CONDITIONS
Official Title
Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female patients treated at Rizzoli Orthopaedic Institute between 01/01/1991 and 31/12/2021
- Age 2 years or older
- Diagnosis of Ewing Sarcoma
- Patients with available clinical and imaging data
You will not qualify if you...
- At least one inclusion criterion not met
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Itituto Ortopedico Rizzoli
Bologna, BO, Italy, 40136
Actively Recruiting
Research Team
C
Costantino Errani
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here